Coronavirus

About Coronavirus

As California’s hospitals continue their life-saving work during the COVID-19 pandemic, the hospital associations continue to advocate on behalf of hospitals and their patients, in addition to offering these tools and resources:

Coronavirus Response Newsletter

CMS Announces Increased Reimbursement for Monoclonal Antibody Administration The Centers for Medicare & Medicaid Services (CMS) has increased the Medicare payment rate for the administration of monoclonal antibodies for the treatment of beneficiaries with COVID-19, effective May 6. In addition, CMS has established a higher reimbursement rate for monoclonal antibody administration performed in a beneficiary’s permanent residence […]

HRSA Announces Availability of Grants for Health Center Construction and Renovation

The Health Resources and Services Administration (HRSA) recently announced the availability of $1 billion in funding available for health centers appropriated by the American Rescue Plan (ARP). To be eligible, an organization must be an existing health center receiving Health Center Program operational support under sections 330(e), (g), (h), and/or (i) of the Public Health Service Act at the time of application […]

Coronavirus Response Newsletter

HRSA Announces Program to Cover COVID-19 Vaccination Costs for Underinsured On May 3, the Health Resources and Services Administration announced a new program — the COVID-19 Coverage Assistance Fund (CAF) — that reimburses providers for vaccinations administered to patients enrolled in health plans that either do not cover vaccination fees or cover them with patient […]

Coronavirus Response Newsletter

CDPH to Provide 60 Days’ Notice Prior to Ending Waiver for Space and Other Flexibilities On April 28, the California Department of Public Health (CDPH) notified hospitals that it will provide at least 60 days’ notice prior to rescinding any of the provisions of All Facilities Letter 20-26.7, its waiver on space and other flexibilities. […]

Coronavirus Response Newsletter

Administration of Johnson & Johnson Vaccine Resumes On April 23, the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and CDC’s Advisory Committee on Immunization Practices recommended resuming administration of the Johnson & Johnson (aka Janssen or J&J) vaccine.